Cargando…
The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study
Purpose: Few studies have examined the relationship between duration of oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer and mortality in routine practice. We examined the association between treatment with 50% versus >85% of a maximal course of adjuvant therapy (eight cycl...
Autores principales: | Sue-Chue-Lam, Colin, Brezden-Masley, Christine, Sutradhar, Rinku, Yu, Amy Y. X., Baxter, Nancy N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378653/ https://www.ncbi.nlm.nih.gov/pubmed/37504338 http://dx.doi.org/10.3390/curroncol30070478 |
Ejemplares similares
-
Randomised controlled trials of non-pharmacological interventions to improve patient-reported outcomes of colonoscopy: a scoping review
por: Sue-Chue-Lam, Colin, et al.
Publicado: (2023) -
Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer
por: Lee, Michelle C. M., et al.
Publicado: (2021) -
Overall Health Care Cost During the Year Following Diagnosis of Colorectal Cancer Stratified by History of Colorectal Evaluative Procedures
por: Paszat, Lawrence, et al.
Publicado: (2021) -
Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program
por: Paszat, Lawrence, et al.
Publicado: (2016) -
Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
por: Eggington, S, et al.
Publicado: (2006)